Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

OBJECTIVES: Many countries have authorized the emergency use of oral antiviral agents for patients with mild-to-moderate cases of coronavirus disease 2019 (COVID-19). We assessed the cost-effectiveness of these agents for reducing the number of severe COVID-19 cases and the burden on Korea’s medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Youngji, Kim, Sun Bean, Radnaabaatar, Munkhzul, Huh, Kyungmin, Yoo, Jin-Hong, Peck, Kyong Ran, Park, Hojun, Jung, Jaehun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Epidemiology 2022
Materias:
COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350420/
https://www.ncbi.nlm.nih.gov/pubmed/35381167
http://dx.doi.org/10.4178/epih.e2022034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350420/
https://www.ncbi.nlm.nih.gov/pubmed/35381167
http://dx.doi.org/10.4178/epih.e2022034

Ejemplares similares